About Biomimiq
Biomimiq is a Healthcare company based in Leiden (Netherlands) founded in 2010. In vitro human skin models are developed for animal-free testing. It operates in the Healthcare and Chemicals & Materials sectors. The company has 43 employees. Its Indian entity Noatum Logistics India Private Limited reported revenue of ₹164 Cr. Biomimiq offers products and services including In Vitro Human Skin Equivalents (HSEs). Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Biomimiq is a biotechnology startup spun-off from the Leiden University Medical Center that services centered around in vitro models of the human skin mimicking both healthy as well as diseased states. The company was formed the exclusive licensing agreement between Leiden University Medical Center and Aeon Astron Europe B.V. and is thus part of the Aeon Astron group. Biomimiqs services are based on what the company refers to as in vitro human skin equivalents or HSEs. The company has developed healthy Leiden epidermal skin model (LEM), healthy full-thickness fibroblast-derived matrix (FDM), healthy full thickness model (FTM), which enable a wide range of in vitro assays. Biomimiq has also developed a range of diseased skin models including skin wound models, skin aging models, and skin infection models to enable screening and MoA studies on drug candidates.
- Headquarters Leiden, Netherlands
- Employees 43
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website biomimiq.com/home
- Legal Name Noatum Logistics India Private Limited
- Date of Incorporation 13 Jun, 2000
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹164 Cr
FY 2025 · +62% YoY
- Indian entity net profit₹3.62 Cr
FY 2025 · 2% margin
- Indian entity EBITDA₹5.12 Cr
FY 2025 · 3% margin
- Investors
- Employee Count43
Associated legal entities of Biomimiq
Biomimiq operates through Noatum Logistics India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Noatum Logistics India Private Limited CIN U63010MH2000PTC127165 | Active | 13 Jun 2000 | Mumbai, Maharashtra | ₹164 Cr | 43 | 3 | View details |
Products & Services of Biomimiq
Biomimiq offers a comprehensive portfolio of products and services, including In Vitro Human Skin Equivalents (HSEs).
Customizable models for skin compound testing and research purposes.
Funding Insights of Biomimiq
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Biomimiq with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2010 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Biomimiq
Biomimiq has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include LifeSciences@Work.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
LifeSciences@Work is recognized as a national accelerator for life sciences startups. | 2008 | lifesciencesatwork.nl | Utrecht, Netherlands |
Investor details for Biomimiq
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Noatum Logistics India Private Limited (Biomimiq)
Noatum Logistics India Private Limited is the primary company behind Biomimiq. The board of Noatum Logistics India Private Limited currently have 3 directors; the longest-serving is Tse Pui Ching, appointed in 2013. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tse Pui Ching DIN 06679220 | Director | 03 Sep 2013 | 13 yrs 1 mo | Noatum Logistics India Private Limited |
| Sheshagiri Kulkarni DIN 00364116 | Director | 01 Mar 2016 | 10 yrs 7 mo | Noatum Logistics India Private Limited |
| Ramon Gallen Antolin DIN 10241432 | Director | 17 Jul 2023 | 3 yrs 3 mo | Noatum Logistics India Private Limited |
Financials of Biomimiq
Figures of Noatum Logistics India Private Limited, the primary company behind Biomimiq, for FY 2025. Revenue was ₹164 Cr (+62% year on year). Net profit was ₹3.62 Cr (2% margin). EBITDA was ₹5.12 Cr (3% margin). Revenue has grown at a compounded annual rate of -3% over three years and +17% over five years.
- ₹164 CrRevenue · FY 2025 · +62% YoY
- ₹3.62 CrNet profit · 2% margin
- ₹5.12 CrEBITDA · 3% margin
- ₹20 LakhPaid-up capital
- 43Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Noatum Logistics India Private Limited are on its company page.
Detailed financial statements for Biomimiq
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Biomimiq
2 dated milestones of Biomimiq, from founding to its latest funding, stage changes and deals.
- Founded Biomimiq is founded.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomimiq
Complete news archive for Biomimiq
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomimiq
Biomimiq was founded in 2010.
Biomimiq is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Biomimiq has 43 employees.
The primary company behind Biomimiq, Noatum Logistics India Private Limited, reported revenue of ₹164 Cr for FY 2025, up 62% year on year.
Biomimiq is a biotechnology startup spun-off from the Leiden University Medical Center that services centered around in vitro models of the human skin mimicking both healthy as well as diseased states. The company was formed the exclusive licensing agreement between Leiden University Medical Center and Aeon Astron Europe B.V. and is thus part of the Aeon Astron group. Biomimiqs services are based on what the company refers to as in vitro human skin equivalents or HSEs. The company has developed healthy Leiden epidermal skin model (LEM), healthy full-thickness fibroblast-derived matrix (FDM), healthy full thickness model (FTM), which enable a wide range of in vitro assays. Biomimiq has also developed a range of diseased skin models including skin wound models, skin aging models, and skin infection models to enable screening and MoA studies on drug candidates.
Biomimiq offers In Vitro Human Skin Equivalents (HSEs).
Biomimiq has 1 investor. Key investors include LifeSciences@Work.
Biomimiq operates through Noatum Logistics India Private Limited.
The legal entities of Biomimiq currently have 3 directors, including Ramon Gallen Antolin, Tse Pui Ching, Sheshagiri Kulkarni.